In the five decades since its inception, the Cancer Research Institute has established itself as a leader in the immunology and tumor immunology research communities. As a well-known and respected organization within these scientific communities, CRI has the ability to convene the world's top immunologists and tumor immunologists whenever there is need to discuss breaking developments or significant challenges in these two fields.
We regularly host conferences and other forums that give dedicated researchers and clinicians an opportunity to gain a comprehensive overview of the immunological landscape, exchange ideas and findings, and advance the field.
The first meeting, Frontiers of Immunology and Cancer Immunology, was held in 1993 and was dedicated to Dr. William B. Coley, commemorating his first clinical use of bacterial vaccines to treat cancer. Since then, the symposia series has attracted leading immunologists in the cancer vaccine and antibody fields, providing them with a comprehensive view of the potential and problems in the development of cancer immunotherapies.
Recent Symposia:
Cancer Immunology & Immunotherapy 2008: From Discovery to Development to Drug
16th Annual International Cancer Immunotherapy Symposium
September 15-17, 2008 - New York City
Cancer and HIV Vaccines 2007: Shared Lessons
15th Annual International Cancer Immunotherapy Symposium
October 4-6, 2007
Click here for information on CRI's other past symposia.
CRI programs also encompass fundraising events, which directly support scientific research initiatives, as well as educational lectures for donors, the media, cancer patients, and the public.